Hasil Pencarian - Moog C

  • Menampilkan 1 - 8 hasil dari 8
Perbaiki Hasil
  1. 1
    P04-36. HIV-1-speficic antibody dependant cellular cytotoxicity (ADCC) médiated by primary NK cells

    P04-36. HIV-1-speficic antibody dependant cellular cytotoxicity (ADCC) médiated by primary NK cells oleh Penichon J, Decoville T, Holl V, Delaporte M, Moog C

    Diterbitkan 2009-10-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection

    P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection oleh Moog C, Schmidt S, Decoville T, Penichon J, Lederle A, Holl V

    Diterbitkan 2009-10-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Anti-HIV and immune modulating activities of IND02

    Anti-HIV and immune modulating activities of IND02 oleh Biedma ME, Connell B, Schmidt S, Lortat-Jacob H, Moog C, Prakash E

    Diterbitkan 2012-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    P04-27. Monoclonal neutralizing antibodies inhibit HIV-1 transfer from immature dendritic cells to human primary CD4 T-lymphocytes

    P04-27. Monoclonal neutralizing antibodies inhibit HIV-1 transfer from immature dendritic cells to human primary CD4 T-lymphocytes oleh Aubertin A, Schmidt S, Decoville T, Peressin M, Holl V, Xu K, Moog C

    Diterbitkan 2009-10-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    P11-20. HIV-1 gp41-specific mucosal IgAs from highly exposed but IgG seronegative women block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection

    P11-20. HIV-1 gp41-specific mucosal IgAs from highly exposed but IgG seronegative women block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection oleh Lopalco L, Reynes J, Moog C, Drillet A, Diomede L, Houimel M, Derrien M, Tudor D, Bomsel M

    Diterbitkan 2009-10-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates

    Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates oleh Moog C, Dereuddre-Bosquet N, Biedma M, Schmidt S, Decoville T, Mangeot I, Zolla-Pazner S, Vcelar B, Katinger D, Holl V, Le Grand R

    Diterbitkan 2012-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group

    P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group oleh Polonis V, Osmanov S, Morris L, Moog C, Montefiori D, Malnati M, Lopalco L, Jansson M, Holmes H, Heyndrickx L, Heath A, Fenyö E, Bongertz V, Alcami J, Scarlatti G, Ramaswamy M, Sattentau Q, Schuitemaker H, Wrin T

    Diterbitkan 2009-10-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans

    Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans oleh Katinger D, Wagner A, Luque I, Crespillo S, Conejero-Lara F, Roger M, Martin C, Mouz N, Mourao S, Farsang A, Notka F, Malcolm K, Bosquet N, Le Grand R, Moog C, Cope A, Shattock R, Lewis DJ, El Habib R

    Diterbitkan 2012-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: